| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8fb0df0b05738afc3f0e0aafced7341 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0648 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
| filingDate |
2019-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_492e8bc2dec6b162f5d891a43554d2b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_628295d1c7c7606ec2f4e0aec8a15758 |
| publicationDate |
2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021308482-A1 |
| titleOfInvention |
Photobiomodulation therapy to treat a degenerative condition of the retina and/or the optic nerve |
| abstract |
Photobiomedulation therapy (PBMT) can be applied to the eye to treat optical neuritis, a sign of multiple sclerosis (MS). The light of PBMT can be directed into the eye, regardless of the position of the eye, by a device that includes an array of light delivery devices and a heat sink lens. The device can be placed proximal to the eye to direct the light into the eye. The light can have one or more wavelengths from 400-1100 nm and can be applied in at least one of a pulsed operating mode, a continuous operating mode, and a super-pulsed operating mode through the light source device to the skeletal muscle. The light signal is applied for a time sufficient to stimulate a phototherapeutic response in the retina and/or the optic nerve. PBMT applied in this manner provides a noninvasive, safe and effective treatment for optic neuritis. |
| priorityDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |